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Abstract. 
 
To investigate the functions of P-cadherin in 
vivo, we have mutated the gene encoding this cell adhe-
sion receptor in mice. In contrast to E- and N-cadherin–
deficient mice, mice homozygous for the P-cadherin 
mutation are viable. Although P-cadherin is expressed 
at high levels in the placenta, P-cadherin–null females 
are fertile. P-cadherin expression is localized to the myo-
epithelial cells surrounding the lumenal epithelial cells 
of the mammary gland. The role of the myoepithelium 
as a contractile tissue necessary for milk secretion is 
clear, but its function in the nonpregnant animal is un-
known. The ability of the P-cadherin mutant female to 
nurse and maintain her litter indicates that the con-
tractile function of the myoepithelium is not dependent 
on the cell adhesion molecule P-cadherin. The virgin 
P-cadherin–null females display precocious differentia-
tion of the mammary gland. The alveolar-like buds in 
virgins resemble the glands of an early pregnant animal 
morphologically and biochemically (i.e., milk protein 
synthesis). The P-cadherin mutant mice develop hyper-
plasia and dysplasia of the mammary epithelium with 
age. In addition, abnormal lymphocyte infiltration was 
observed in the mammary glands of the mutant ani-
mals. These results indicate that P-cadherin–mediated 
adhesion and/or signals derived from cell–cell interac-
tions are important determinants in negative growth 
control in the mammary gland. Furthermore, the loss of 
P-cadherin from the myoepithelium has uncovered a 
novel function for this tissue in maintaining the undif-
ferentiated state of the underlying secretory epithe-
lium.
 
C
 
lassical
 
 cadherins, such as E-, N-, and P-cadherin,
play critical roles in tissue morphogenesis as evi-
denced by studies in 
 
Xenopus
 
 and mice (Kintner,
1992; Hermiston and Gordon, 1995). Cadherins are a fam-
ily of glycoproteins involved in Ca
 
11
 
-dependent, homo-
typic cell–cell adhesion (Takeichi, 1995; Gumbiner, 1996).
Classical cadherins have five extracellular domains, one
transmembrane domain, and a highly conserved cytoplas-
mic domain. Two subclasses of cadherins, E- and P-cad-
herin, are detected in various epithelial tissues of mouse
embryos (Nose and Takeichi, 1986). Antibody perturba-
tion experiments have shown that E- and P-cadherin func-
tion cooperatively in the histogenesis of embryonic lung
and lip skin in organ explant cultures (Hirai et al., 1989
 
a
 
, 
 
b
 
).
In the case of the lung primordia, addition of anti-E-cad-
herin antibodies resulted in collapsed lobules with little lu-
minal space, while anti–P-cadherin antibodies had a less
dramatic effect. However, a mixture of both antibodies
had a synergistic effect resulting in a severely distorted ep-
ithelium that could not undergo the normal branching pro-
cess. In similar experiments performed on embryonic skin,
P-cadherin appears to be more important compared with
E-cadherin, but again disruption of both E- and P-cad-
herin produced the more dramatic effect on skin morpho-
genesis. Taken together, these studies suggest that both
E- and P-cadherin play important roles in maintaining the
structural integrity of epithelial tissues.
The cadherin cytoplasmic domain interacts with a group
of proteins termed catenins, which link the cadherin to the
actin cytoskeleton. Interaction with both the catenins and
the actin cytoskeleton is necessary for full cadherin adhe-
sive activity (Kemler, 1993). Either 
 
b
 
-catenin or plakoglo-
bin, which are members of the Armadillo family of pro-
teins (Peifer, 1995), binds directly to the cadherin. In
addition to playing structural roles in cell–cell adhesion,
these two catenins, along with Armadillo, appear to have
signaling roles, although the exact mechanism is not fully
understood. Armadillo is the product of a 
 
Drosophila
 
 seg-
ment polarity gene and is part of the wingless signaling
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pathway, downstream of Zeste-White 3 kinase (Peifer et al.,
1994). 
 
b
 
-catenin and plakoglobin have been implicated in
formation of mesoderm and the anterior-posterior axis in the
 
Xenopus
 
 embryo (Heasman et al., 1994; Funayama et al.,
1995). Recently, 
 
b
 
-catenin was shown to interact with the
transcription factor, LEF-1, providing evidence that 
 
b
 
-cate-
nin can regulate gene expression (Behrens et al., 1996).
 
a
 
-catenin, which shares homology with the cytoskeleton-
associated protein vinculin, binds the cadherin indirectly
through 
 
b
 
-catenin or plakoglobin. Like vinculin, 
 
a
 
-catenin
binds to both 
 
a
 
-actinin and actin (Knudsen et al., 1995;
Rimm et al., 1995). Thus, 
 
a
 
-catenin serves to link the cad-
herin/catenin complex to the actin cytoskeleton.
Cell adhesion molecules, including the cadherins, are
known to play important roles in mammary gland morpho-
genesis. The mammary gland develops postnatally under
the proper hormonal stimuli during puberty and adoles-
cence. The morphogenesis of the mammary ductal tree oc-
curs when the end buds invade the surrounding fatty
stroma until they reach the edge of the fat pad. The end
buds of the mammary ducts represent the growth points
for ductal morphogenesis. The end buds consist of basally
located cap cells and lumenal epithelial cells (Williams and
Daniel, 1983). The cap cells are loosely adhering epithelial
cells that lack cytoplasmic polarity and a well organized cy-
toskeleton.
 
 
 
During early pregnancy lateral buds differenti-
ate from the ducts and during the second half of pregnancy
these alveoli develop into fully differentiated secretory
lobules. These morphogenetic events are accompanied by
cellular differentiation leading to development of secre-
tory epithelial cells which are capable of synthesizing and
secreting milk proteins.
The mammary duct consists of two main cell types, the
lumenal epithelial cells and a surrounding monolayer of
myoepithelial cells with a closely apposed basement mem-
brane. The myoepithelial cells are thought to differentiate
from the cap cells extending their cell processes laterally
along the duct. In the pregnant animal, the myoepithelium
is present all along the duct and in the alveoli, where myo-
epithelial cells are basket shaped resulting in space be-
tween the cells allowing direct contact between the alveo-
lar epithelial cells and the basal lamina. In contrast with
other tissues, the expression pattern of E- and P-cadherin
in the mammary gland is very distinct. In the mouse, cap
cells and myoepithelial cells express P-cadherin while the
lumenal epithelial cells express E-cadherin (Daniel et al.,
1995). Function-blocking antibodies were used in situ to
examine the role of E- and P-cadherin in maintaining the
tissue integrity of the end bud (Daniel et al., 1995). Anti-
body to E-cadherin induced disruption of the epithelium
resulting in freely floating epithelial cells in the lumen. In
contrast, antibody to P-cadherin had no effect on the lu-
menal layer but partially disrupted the basally located cap
cell layer. These data show that E- and P-cadherin are im-
portant for maintaining the integrity of the different cell
layers of the mammary duct.
The cell–cell and cell–matrix interactions of myoepithe-
lial cells may play an important role in maintaining the
structural integrity of the mammary duct. Myoepithelial
cells are specialized contractile cells, whose ultrastructure
is reminiscent of smooth muscle cells (Deugnier et al., 1995).
They express smooth muscle contractile and cytoskeletal
proteins such as 
 
a
 
-smooth muscle actin (Radnor, 1972).
However, they are true epithelial cells since cytokeratin is
the major component of the intermediate filament system,
they form desmosomes, hemidesmosomes, and adherens
junctions, and are permanently separated from the connec-
tive tissue by the underlying basement membrane (Franke et
al., 1980; Sonnenberg et al., 1986; Rasbridge et al., 1993).
Recent experiments suggest that myoepithelial cells may
have an important role in branching morphogenesis in the
mammary gland (Niranjan et al., 1995). Hepatocyte growth
factor/scatter factor (HGF/SF)
 
1
 
 is produced by the fibro-
blasts in the breast. The lumenal epithelium and myoepi-
thelium respond differently to HGF/SF; which acts as a
mitogen for the lumenal cells while it behaves like a mor-
phogenic factor for the myoepithelial cells. Human myo-
epithelial cells exposed to HGF/SF form extended branching
tubules while lumenal epithelial cells did not show any
morphological changes (Niranjan et al., 1995). Further-
more, overexpression of HGF/SF in the mammary gland
of transgenic mice leads to precocious alveolar differentia-
tion (Takayama et al., 1997). These data suggest that myo-
epithelial cells may play an important role in branching
morphogenesis in the mammary gland.
To understand the role of the P-cadherin adhesion re-
ceptor in mouse development, we mutated the P-cadherin
gene in embryonic stem (ES) cells and introduced the
mutation into the mouse germ line (Capecchi, 1989). In
contrast to E- and N-cadherin knockout mice, the P-cad-
herin–deficient mice are viable and fertile. However, the
P-cadherin–null females exhibit precocious differentiation
of the mammary gland and display mammary hyperplasia
later in life. The P-cadherin–deficient mice provide us with
a valuable model to determine the role of P-cadherin in
cell proliferation and differentiation in the mammary gland.
 
Materials and Methods
 
Derivation of Mutant Mice
 
The genomic structure of the mouse P-cadherin gene was reported previ-
ously (Hatta et al., 1991). An EcoRI-EcoRI DNA fragment (8.5 kb) was
isolated from lambda clone, PG21, and subcloned into Bluescript KS
(Stratagene, La Jolla, CA). The neo expression cassette, pMC1neo (Tho-
mas and Capecchi, 1987), was digested with XhoI-SalI, and subcloned into
a unique XhoI site in exon 11. The BamHI-BamHI DNA fragment was
subcloned into a plasmid containing the pMC1-HSVTK cassette (Man-
sour et al., 1988). The construct was linearized with NotI and electropo-
rated into D3 ES cells (Doetschman et al., 1985), and colonies were se-
lected with G418 and gancyclovir (a gift from Syntex Corp.) as described
(George et al., 1993). Homologous recombination events were screened
by Southern blot analysis (Sambrook et al., 1989). An EcoRI-BamHI ge-
nomic DNA fragment (0.7 kb) located immediately 5
 
9
 
 to the short arm of
the targeting vector was used as a probe. The targeted ES clones were in-
jected into blastocysts from C57Bl/6J mice (Bradley, 1987). The mice were
genotyped by Southern blot analysis or PCR. One pair of primers corre-
sponding to the intron/exon borders of exon 11 were used in the PCR re-
actions to amplify the wild-type and mutant alleles: P11F, 5
 
9
 
-TCCTTTCC-
AGCTACACCAT-3
 
9
 
 and P11R, 5
 
9
 
-AAGCTCTCACCACTGTCTGTG-3
 
9
 
.
Unpurified tail DNA was used for the PCR reactions (Hanley and Merlie,
1991). Temperature cycling conditions for the Perkin Elmer 480 PCR ma-
chine were 94
 
8
 
C for 1 min; 65
 
8
 
C for 2 min; and 72
 
8
 
C for 3 min for 40 cycles.
PCR products were resolved on a 1.6% agarose gel.
 
1. 
 
Abbreviations used in this paper
 
: APC, adenomatous polyposis coli;
ECM, extracellular matrix; ES, embryonic stem; HGF/SF, hepatocyte
growth factor/scatter factor; HSV, Herpes simplex virus; PCD-1, P-cad-
herin antibody. 
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Western Immunoblotting
 
Decidual tissue from wild-type, heterozygous, and homozygous concep-
tuses was isolated on day 8 of gestation. The protein lysates were sub-
jected to SDS-PAGE (Laemmli, 1970), and the resolved proteins were
transferred electrophoretically to nitrocellulose. The blot was reacted with
antibodies to P-cadherin (PCD-1; Nose and Takeichi, 1986) and protein
bands were visualized using the ECL (Amersham Corp., Arlington
Heights, IL) detection system.
 
Morphological and Histological Analysis
 
The thoracic no. 3 and/or inguinal no. 4 mammary glands were examined.
Whole mount staining of the glands was performed as previously de-
scribed (Williams and Daniel, 1983). The mammary glands were fixed
overnight in Tellyesniczky’s fixative (5% formalin, 5% acetic acid, 70%
EtOH). The fixed glands were defatted in acetone, stained with: hematox-
ylin (0.65g FeCl
 
3
 
, 67.5 ml H
 
2
 
O, 8.7 ml stock hematoxylin [10% in 95% eth-
anol], and 1,000 ml 95% ethanol, adjust pH 1.25 with concentrated HCl),
and then rinsed in tap water, dehydrated in increasing concentrations of
ethanol to xylene, and photographed with a dissecting microscope.
For histology, mammary glands were fixed in 10% formalin, processed
for paraffin sectioning, and stained with hematoxylin and eosin.
 
Immunohistochemistry
 
Immunostaining for P- and E-cadherin, 
 
a
 
-smooth muscle actin, and
caseins was performed on frozen sections of mammary tissue as described
previously (Daniel et al., 1995). Tissue was embedded in Tissue-Tek OCT
compound (Miles Diagnostic Division, Elkhart, IN) and frozen in an iso-
pentane/dry ice bath. 8-
 
m
 
m sections were cut with a Zeiss cryotome,
placed on Superfrost Plus slides (Fisher Scientific, Pittsburgh, PA), post-
fixed in 1:1 acetone/methanol at 
 
2
 
20
 
8
 
C for 10 min, air dried, and stored at
 
2
 
20
 
8
 
C. Antibodies were diluted in 5% skim milk/PBS except for casein
antibody (1% goat serum/PBS) as follows: rat monoclonal PCD-1 (1:200),
rat monoclonal ECCD-2 (1:500; Shirayoshi et al., 1986), mouse mono-
clonal 
 
a
 
-smooth muscle actin (clone 1A4, 1:400; Sigma Chemical Co., St.
Louis, MO), and rabbit polyclonal casein (1:1,000; a gift from Charles
Daniel, University of California, Santa Cruz). The samples were incu-
bated overnight with primary antibodies except casein antibody (1 h),
washed with PBS, incubated with species specific biotinylated secondary
antibodies (Amersham), washed with PBS, and processed with Vectastain
ABC reagents (Vector Labs, Burlingame, CA), regular or elite, and
washed with PBS. The casein antibody washes contained 1% goat serum.
The peroxidase substrate was applied, sections were lightly counterstained
with hematoxylin, dehydrated, and coverslipped. The samples were pho-
tographed with a Nikon Optiphot microscope.
 
Results
 
Generation of P-Cadherin–deficient Mice
 
To construct a targeting vector for the P-cadherin gene
(Fig. 1 
 
A
 
), a neomycin phosphotransferase (neo) expres-
sion cassette (pMC1neo; Thomas and Capecchi, 1987) was
inserted into a unique XhoI site in exon 11 (Nose et al.,
1987; Hatta et al., 1991). This disrupts the open reading
frame of the P-cadherin gene in the extracellular domain
of the protein. The neo cassette, containing a polyadenyla-
tion signal, was placed in the same transcriptional orienta-
tion as the P-cadherin gene thus serving to truncate any
P-cadherin/neo fusion transcript. The vector includes 2.5
kb of genomic sequences 5
 
9
 
 of the neo gene, 5 kb on the 3
 
9
 
side, and a flanking Herpes simplex virus (HSV) thymi-
dine kinase expression cassette (pMC1-tk; Mansour et al.,
1988). A similar construct was used successfully to inacti-
vate the N-cadherin gene in mice (Radice et al., 1997).
The linearized targeting vector was electroporated into
D3 ES cells (Doetschman et al., 1985), and the electropo-
rated cells were subjected to positive/negative selection
(Mansour et al., 1988) using G418 and gancyclovir. One of
86 double-resistant ES cell clones (P78) underwent homol-
ogous recombination at the P-cadherin locus as deter-
mined by Southern blot analysis (Fig. 1 
 
B
 
). Hybridization
with a neo probe failed to detect any additional sites of in-
tegration (data not shown). The targeted clone was in-
jected into host C57BL/6 blastocysts, and the blastocysts
were transferred to the uteri of pseudopregnant females.
Germline transmission of the mutant allele was achieved
with the targeted ES clone. The heterozygous mice did not
display any obvious abnormalities in comparison with their
wild-type littermates.
 
P-Cadherin Mutant Mice Are Viable and Fertile
 
To examine whether animals homozygous for the P-cad-
herin mutation were viable, heterozygous animals were in-
tercrossed and genotypes of the progeny were determined
by Southern blot or by PCR analysis. Mice homozygous
for the P-cadherin mutation were detected among the in-
tercross progeny (Fig. 1 
 
C
 
). The genotypes of the progeny
showed a good fit to Mendelian distribution (107 
 
1
 
/
 
1
 
:
211 
 
2
 
/
 
1
 
:114 
 
2
 
/
 
2
 
). Homozygous P-cadherin–deficient mice
did not show any overt developmental abnormalities and
were indistinguishable from their heterozygous or wild-
type littermates on the basis of size, activity, or fertility. To
determine whether wild-type P-cadherin protein was
present in homozygous mice, we examined the uterine de-
Figure 1. Targeted disruption of the P-cadherin gene. (A) Sche-
matic representation of the expected gene replacement at the
P-cadherin locus. Exons are represented as closed boxes. The
MC1-neomycin resistance cassette and MC1-thymidine kinase
cassette are designated Neo and HSVtk, respectively; arrows in-
dicate the orientation of the genes. The flanking probe used for
screening ES cell clones and genotyping mice is shown (Probe).
Restriction endonuclease sites are abbreviated as follows: E,
EcoRI;  S, SphI; Sa, SacI. The PCR primers, P11F and P11R, used
for genotyping are shown. (B) Southern blot analysis of a tar-
geted ES cell clone. The wild-type (WT) and knockout (KO) ge-
nomic fragments are indicated. (C) PCR blot analysis of P-cad-
herin intercross progeny indicating the genotypes. The wild-type,
0.17 kb, and mutant, 1.2 kb, PCR products are shown. (D) West-
ern analysis of placental lysates from P-cadherin intercross prog-
eny. The arrowhead indicates the 118-kD P-cadherin protein rec-
ognized by the mAb PCD-1. No P-cadherin protein was detected
in the homozygous mice. kb, kilobases; m, markers. 
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cidua of pregnant mice since P-cadherin protein is very
abundant in this maternal tissue. The decidual tissue with-
out the embryo and extraembryonic membranes was iso-
lated from day 8 conceptuses of wild-type, heterozygous,
and homozygous mice. Western blot analysis of decidual
lysates was performed using monoclonal antibody, PCD-1,
which recognizes the amino terminus of the protein (Nose
et al., 1990). No full-length or truncated P-cadherin pro-
tein was detected in the mutant, while a reduced amount
of P-cadherin protein was present in the heterozygote
(Fig. 1 
 
D
 
). In addition, a pan-cadherin polyclonal antibody
(Takeichi et al., 1990) which recognizes the conserved
cytoplasmic domain of classical cadherins did not detect
P-cadherin in the mutant decidual tissue (data not shown).
To determine if loss of P-cadherin affected litter size, hy-
brid 129Sv/C57BL mutant males and females were mated.
The P-cadherin–null females had litter sizes (average 8.8,
114 pups/13 litters) comparable to their wild-type litter-
mates. The ability of the P-cadherin mutant females to
nurse and maintain a normal size litter indicates that the
contractile function of the myoepithelium is not depen-
dent on the cell adhesion molecule P-cadherin.
 
Loss of P-Cadherin from Myoepithelial Cells Leads to 
Alveolar Differentiation in Virgin Females
 
To examine cadherin expression in the mutant mammary
duct, immunohistochemistry was performed on sections of
mammary tissue. P-cadherin was localized to the myoepi-
thelial cells surrounding the lumenal epithelial cells in the
wild-type, but absent from the mutant duct (Fig. 2, 
 
A
 
 and
 
D
 
). The presence of myoepithelium in the mutant duct
was confirmed by smooth muscle actin staining (Fig. 2, 
 
B
 
and 
 
E
 
), a marker for myoepithelial cells (Radnor, 1972).
E-cadherin expression was similar in wild-type and mutant
ducts (Fig. 2, 
 
C
 
 and 
 
F
 
), thus demonstrating that E-cad-
herin expression was not affected by mutating the closely
linked P-cadherin gene (Hatta et al., 1991).
During puberty the end buds of the mammary ductal tree
actively penetrate the surrounding adipose stroma, P-cad-
herin has been shown to be expressed in the cap cells of
the terminal end bud (Daniel et al., 1995). No difference in
the extent of branching morphogenesis was observed in the
mammary glands of mutant mice compared with their wild-
type littermates at 5 wk of age, before puberty is complete
(data not shown). However, we observed an unexpected
phenotype when mammary glands from postpubescent
virgin females (10 wk old) were examined by whole-mount
staining. Wild-type animals had normal ductal morpho-
genesis, while the mutant animals displayed precocious al-
veolar differentiation resembling an early pregnant gland
(Fig. 3, 
 
A
 
 and 
 
B
 
). The mammary glands from mutant male
mice appeared normal; no alveolar differentiation was ob-
Figure 2. Cadherin expression in wild-type and mutant mammary ducts. Mammary gland sections of wild-type (A–C) and mutant (D–
F) animals were immunostained for P-cadherin (A and D), smooth muscle actin (B and E), and E-cadherin (C and F). P-cadherin is
present in the myoepithelial cells surrounding the lumenal epithelial cells in the wild-type duct (A) and absent in the mutant duct (D). A
diffuse nonspecific background staining was observed in the mutant (D), but the characteristic dark linear staining of the myoepithelial
cells (A) was absent in the mutant. Myoepithelial cells are present in both the wild-type (B) and mutant (E) as shown by the smooth
muscle actin staining. E-cadherin expression appears similar in wild-type (C) and mutant (F) ducts. The arrowheads indicate lumenal
epithelial cells and arrows indicate myoepithelial cells. Original magnification 1253.
Figure 3. Structure of normal and mutant mammary glands in
virgin female mice. Whole-gland stain of (A) wild-type and (B)
mutant mammary gland from 10-wk-old virgin animals. P-cad-
herin–deficient virgin females display precocious alveolar differ-
entiation. Original magnification 103.  
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served (data not shown). To determine whether the mu-
tant mammary glands exhibited biochemical changes asso-
ciated with differentiation, milk protein production was
examined using a polyclonal antibody against caseins. The
wild-type virgin animal did not express casein(s) while the
mutant expressed casein(s) at levels similar to a pregnant
animal (Fig. 4, 
 
A–C
 
). These data indicate that loss of P-cad-
herin leads to precocious alveolar differentiation which is
morphologically and biochemically similar to an early preg-
nant wild-type gland.
 
A Mutation in the P-Cadherin Gene Predisposes Mice 
to Focal Mammary Hyperplasia and Dysplasia
 
As demonstrated in various animal models of mammary
tumorigenesis, precocious alveolar differentiation is often
associated with neoplastic lesions, an initial step in tumor
development (Cardiff and Muller, 1993). Therefore, the
P-cadherin mutant mice and their heterozygous and wild-
type littermates were maintained until 2 yr of age. No pal-
Figure 4. Expression of milk protein in P-cadherin–null virgin mice. Mammary gland sections of wild-type virgin (A) , mutant virgin (B),
and wild-type pregnant day 14 (C) animals were immunostained with a polyclonal antibody against caseins. The P-cadherin–deficient
virgin mammary gland express casein(s) similarly to a pregnant animal. The wild-type virgin gland was counterstained to distinguish the
ducts. Original magnification 623.
Figure 5. P-cadherin mutant mice develop focal hyperplasia and dysplasia with age. Histology of virgin mammary tissue from wild-type
(A) and mutant (B–F) animals, 19–24 mo of age. The mutant mice (B) exhibit extensive alveolar differentiation compared with their
control littermates (A). Higher magnification of the alveoli (C). P-cadherin mutant animals develop fibroblastic (D) and secretory hy-
perplasia (E) and exhibit extensive lymphocyte infiltration (F). The lymphocytes are concentrated around the ducts (arrowhead). A
portion of the lymph node is shown (arrow). Original magnifications: (A and B) 12.53; (C–F) 313. 
pable tumors were observed in the aged P-cadherin mu-
tant animals. However, upon histological examination of
the mammary glands, focal alveolar hyperplasia and ductal
dysplasia were observed in the mutants. Comparison of a
20-mo-old wild-type and mutant virgin female gland reveals
the extent of alveolar hyperplasia observed in the mutants
(Fig. 5, A and B). The clusters of alveoli are shown at higher
magnification (Fig. 5 C). A 24-mo-old virgin mutant ani-
mal displays ductal dysplasia and stromal/fibroblastic hy-
perplasia (Fig. 5 D). Secretory vacuoles were observed in
the alveoli of a 20-mo-old virgin animal consistent with a
differentiated hyperplastic phenotype (Fig. 5 E). In addi-
tion, extensive periductal lymphocyte infiltration was ob-
served in the interstitial space of the mutant glands (Fig. 5
F). Furthermore, several multiparous mutant females (15
mo old) exhibited extensive mammary hyperplasia and dys-
plasia, however, palpable mammary tumors were not ob-
served (data not shown). It should be noted that P-cad-
herin is not expressed in the epithelium which becomes
hyperplastic, but confined to the surrounding myoepithe-The Journal of Cell Biology, Volume 139, 1997 1030
lium which appears normal in the mutant animals. In con-
clusion, mutation of the P-cadherin gene predisposes ani-
mals to focal hyperplasia and dysplasia as well as leading
to an increase in lymphoid cells in the mammary gland.
Discussion
Gene inactivation of the classical cadherins, E- and N-cad-
herin, results in embryonic lethality at the pre- and postim-
plantation stage, respectively (Larue et al., 1994; Riethmacher
et al., 1995; Radice et al., 1997). Here we report the mutation
of a third classical cadherin, P-cadherin, that is compatible
with normal embryonic development. Although P-cadherin
is expressed at high levels in placenta and testis, P-cad-
herin–null females and males are both fertile. E- and P-cad-
herin are often coexpressed in embryonic and adult tissues,
for example, both cadherins are present in the notochord
and basal layer of the epidermis. In these tissues, E-cad-
herin may functionally substitute for P-cadherin in the mu-
tant animals thus explaining their viability. However, re-
cently, a distinct pattern of expression of E- and P-cadherin
was reported for the mouse mammary gland (Daniel et al.,
1995). The mammary duct consists of two main cell types,
the lumenal epithelial cells and an outer monolayer of myo-
epithelial cells with a closely apposed basement membrane.
E-cadherin expression is restricted to the lumenal epithe-
lial cells, while P-cadherin is expressed in the surrounding
myoepithelial cells. We observed an unexpected phenotype
in the mammary glands of the mutant animals. Loss of P-cad-
herin resulted in cell proliferation and differentiation of the
mammary epithelium in virgin female animals.
Ductal morphogenesis in the mammary gland occurs dur-
ing puberty when the end buds of the ducts invade the sur-
rounding fatty stroma until they reach the edge of the fat
pad. The cells surrounding the end buds, called cap cells,
are thought to play an important role in ductal growth and
branching morphogenesis. P-cadherin is expressed by the
cap cells and function-blocking antibodies can disrupt the
cellular integrity of the end bud (Daniel et al., 1995). How-
ever, ductal morphogenesis appears normal in the mutant
mice, indicating that P-cadherin is not required by the cap
cells for invasion of the surrounding fat pad. There are
presumably other cell adhesion molecules expressed by the
cap cells which can functionally substitute for P-cadherin
in the mutant mammary glands. Normally, the mammary
gland does not differentiate fully until the onset of preg-
nancy when lateral buds develop as side branches of the
mammary tree. The alveoli develop further during the sec-
ond half of pregnancy into fully differentiated secretory
lobules capable of synthesizing and secreting milk pro-
teins. The P-cadherin–deficient females display precocious
differentiation of the mammary epithelium similar to an
early pregnant animal. Furthermore, the mutant virgin
glands synthesize milk protein (i.e., casein) indicative of a
differentiated mammary epithelium.
How might loss of P-cadherin cause the mammary gland
phenotype? The possibility that P-cadherin is normally
downregulated during early pregnancy leading to alveolar
differentiation is intriguing. However, Northern blot anal-
ysis did not detect any change in P-cadherin expression be-
tween virgin and early, mid, or late pregnant mammary
glands (D’Cruz, C.M., G.L. Radice, and L.A. Chodosh,
unpublished data). The fact that the P-cadherin–null fe-
males lactate and nurse their pups implies that the myoep-
ithelium can still perform its function as a contractile tis-
sue, however, subtle defects in cell adhesion may be
possible. While there is considerable evidence for induc-
tive signals from the stroma and extracellular matrix
(ECM) affecting the differentiation of the lumenal epi-
thelium (Roskelley et al., 1995), there is very little infor-
mation about the role of the myoepithelium in this pro-
cess, even though it separates the stroma and basal lamina
from the lumenal epithelial cells. The myoepithelium is sit-
uated in a unique position to regulate signals from the sur-
rounding ECM and stroma to the underlying epithelium,
the indirect regulation model (Fig. 6 A). The myoepithe-
lium consists of a monolayer of cells that probably does
not represent a physical barrier per se, but it may act as a
filter to transmit specific signals to the underlying epithe-
lium. P-cadherin–mediated adhesion may be important for
the assembly of other junctional complexes. A cell adhesion
defect may perturb intercellular communication (i.e., gap
junction assembly) in the myoepithelium leading to altered
growth signals. The loss of P-cadherin may affect the func-
tion of other cell adhesion molecules, for example, integrin-
mediated ECM interactions may be compromised leading
to changes in cell morphology of the myoepithelial cells.
In Drosophila, armadillo, the b-catenin homologue, is a
segment polarity gene acting in the wingless signaling path-
way. As in vertebrates, it also interacts with cadherins and
is localized to adherens junctions. In Drosophila, the func-
tions of armadillo in adherens junctions and wingless sig-
naling are competitive. The segment polarity defect of a
weak armadillo allele can be partially rescued by making
the flies heterozygous for DE-cadherin (Cox et al., 1996).
Figure 6. Possible models for regulation of mammary gland dif-
ferentiation by P-cadherin. (A) The indirect regulation model is
based on a cell adhesion defect. For example, inductive signals
from the surrounding ECM (basal lamina) and/or stroma may
more easily permeate a less cohesive myoepithelium leading to
differentiation of the epithelium. (B) The direct regulation model
is based on a P-cadherin–mediated cell signaling defect. For ex-
ample, loss of P-cadherin may cause the myoepithelium to relay a
positive signal(s), or alternatively, it may relieve an inhibitory sig-
nal(s) resulting in differentiation of the lumenal epithelium. The
cell adhesion and cell signaling models are not mutually exclusive.Radice et al. P-Cadherin–deficient Mice 1031
The suppression of the armadillo mutation is thought to
occur because there is a reduction in the amount of DE-
cadherin thus freeing up some of the wild-type maternal
store of armadillo protein, allowing it to function in the
wingless pathway. Similar competitive interactions have
been seen in Xenopus, where increases in cadherin levels
can block action of b-catenin in Wnt signaling as moni-
tored by inhibition of axis duplication (Fagotto et al., 1996).
In both these cases, there appears to be a competition be-
tween the b-catenin bound to the cytoplasmic tail of cad-
herin and the free cytoplasmic b-catenin involved in the
wingless/Wnt signaling pathway.
The cadherin/catenin adhesion complex and the Wnt
signaling pathway share a common component, b-catenin.
Data from transgenic and mutant mice suggest that the
P-cadherin–null phenotype may be due to activation of the
Wnt signaling pathway. Transgenic mice that overexpress
Wnt-1 in the mammary gland develop extensive alveolar
hyperplasia and adenocarcinomas (Tsukamoto et al., 1988).
In addition, mutation of another member of the Wnt sig-
naling pathway, Adenomatous polyposis coli (APC), pre-
disposes mice to focal alveolar hyperplasia and carcinomas
(Moser et al., 1993). APC is a negative regulator of the in-
tracellular b-catenin pool, hence when APC is active the
cytoplasmic pool of b-catenin is very low. When the Wnt
pathway is activated, APC is turned off, and b-catenin ac-
cumulates in the cytoplasm. b-catenin can then interact
with the DNA binding proteins of the T cell factor-lym-
phoid enhancer factor (Tcf-Lef) family to activate tran-
scription of target genes (Behrens et al., 1996). The loss of
P-cadherin may increase the available cytoplasmic b-cate-
nin thus activating the Wnt signaling pathway resulting in
transcription of growth factor genes whose gene products
induce differentiation of the neighboring epithelial cells,
the direct regulation model (Fig. 6 B). This scenario assumes
that APC cannot efficiently inactivate the excess b-catenin
present in the P-cadherin–deficient mammary gland.
Ectopic or overexpression of several proteins including
Wnt1 (Tsukamoto et al., 1988), growth hormone (Bchini
et al., 1991), HGF/SF (Takayama et al., 1997), and stromel-
ysin1 (Sympson et al., 1994) lead to extensive alveolar hy-
perplasia and mammary tumors in transgenic mice. The
extent of precocious alveolar differentiation observed in
the P-cadherin–deficient mice appears less dramatic in
comparison to these other transgenic strains. No palpable
tumors were observed in the mutant animals, although, fo-
cal hyperplastic and dysplastic lesions were observed in
the mutant mammary glands upon necropsy. Hyperplasia
was also observed in the salivary gland where P-cadherin
is normally expressed in the myoepithelial cells (Ferreira-
Cornwell, M.C. and G.L. Radice, unpublished data). The
finding that disruption of P-cadherin function alone is not
sufficient to induce mammary tumors, suggests that addi-
tional genetic lesion(s) are necessary to progress beyond
the hyperplastic phenotype.
P-cadherin is also expressed in myoepithelial cells of the
human mammary gland suggesting that loss of function of
this cell adhesion molecule may promote cell growth and
differentiation in the human breast. While most attention
has focused on the role of E-cadherin in breast cancer, our
data suggest that P-cadherin may also be involved. Loss of
heterozygosity (LOH) of 16q22.1 has been implicated in
many types of cancer including breast (Birchmeier and
Behrens, 1994). E- and P-cadherin are tandemly arranged
at this locus separated by only 32 kb of genomic DNA
(Bussemakers et al., 1994). While cadherin expression has
been examined extensively in the tumor tissue itself, per-
turbation of cadherin function in the surrounding myoepi-
thelium has not been addressed. Germline mutations in
the human P-cadherin gene may predispose women to
breast cancer since hyperplastic growth is an early step in
tumor development.
Recently, a novel cadherin, H-cadherin, was found to be
expressed in human mammary epithelial cells (Lee, 1996).
H-cadherin lacks a cytoplasmic domain and is most similar
to T-cadherin (Ranscht and Dours-Zimmermann, 1991). Its
expression was found to be significantly reduced in human
breast carcinoma cell lines and primary breast tumors (Lee,
1996). Furthermore, transfection of H-cadherin into the breast
cancer cell lines led to a decreased cell growth rate and loss
of anchorage-independent growth in soft agar. These data
suggest that two distinct cadherins, H- and P-cadherin, are
involved in negative growth control in the mammary gland.
Several loss of function mutations in the mouse result in
disruption of mammary gland development and function.
Mutations in cyclin D1 (Sicinski et al., 1995), activin/inhibin
bB (Vassalli et al., 1994), progesterone (Lydon et al., 1995),
and prolactin receptors (Ormandy et al., 1997), and Stat5a
(Liu et al., 1997) all result in inhibition of lobuloalveolar
outgrowth in the mammary gland. All these gene products
are positive effectors in a signaling pathway(s) leading to
alveolar cell proliferation and differentiation. In contrast,
P-cadherin appears to act as a negative regulator of cell
growth and differentiation in the mammary gland. Its absence
leads to precocious alveolar differentiation in virgin animals.
In conclusion, gene targeting of the cell adhesion recep-
tor, P-cadherin, has uncovered a novel function for this
molecule in negative growth control of the mammary gland.
The mechanism by which P-cadherin acts to control cell
growth remains to be determined. No obvious cell adhe-
sion defect has been observed in the myoepithelium of the
mutant animals so far, suggesting the mammary gland phe-
notype may result from perturbation of cellular signals in-
volved in negative growth control.
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